| RS2480502053 |
FOXC1
|
Health Risk |
Pathogenic |
— |
| RS2480502065 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502104 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502130 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502393 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502418 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502469 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502495 |
FOXC1
|
Health Risk |
Likely pathogenic |
— |
| RS2480502500 |
FOXC1
|
Health Risk |
Likely pathogenic |
FOXC1-related disorder, Anterior segment dysgenesis 3 |
| RS2480502524 |
FOXC1
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502731 |
FOXC1
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502742 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502767 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502800 |
FOXC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480502820 |
FOXC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504227 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504244 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504308 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504570 |
FOXC1
|
Health Risk |
Likely pathogenic |
FOXC1-related disorder, FOXC1-related disorder |
| RS2480504690 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504901 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480504935 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480505023 |
FOXC1
|
Health Risk |
Likely pathogenic |
— |
| RS2480505086 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480505189 |
FOXC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face |
| RS2480505369 |
FOXC1
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480505650 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480505702 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480506067 |
FOXC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480506120 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480506700 |
FOXC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Anterior segment dysgenesis 3 |
| RS2480507296 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480507628 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2480508084 |
ITK
|
Health Risk |
Likely pathogenic |
Lymphoproliferative syndrome 1, Lymphoproliferative syndrome 1 |
| RS2480551478 |
ITK
|
Health Risk |
Likely pathogenic |
Lymphoproliferative syndrome 1, Lymphoproliferative syndrome 1 |
| RS2480557976 |
PDE6A
|
Health Risk |
Likely pathogenic |
— |
| RS2480559806 |
ITK
|
Health Risk |
Pathogenic |
Lymphoproliferative syndrome 1, Lymphoproliferative syndrome 1 |
| RS2480559834 |
ITK
|
Health Risk |
Pathogenic |
Lymphoproliferative syndrome 1, Lymphoproliferative syndrome 1 |
| RS2480564545 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480565076 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480565963 |
TBC1D7
|
Health Risk |
Likely pathogenic |
— |
| RS2480574461 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480577993 |
PDE6A
|
Health Risk |
Likely pathogenic |
PDE6A-related disorder, PDE6A-related disorder |
| RS2480580458 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480581026 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480581122 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480589655 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS2480589765 |
DNAJC21
|
Health Risk |
Likely pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS2480589884 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480590275 |
DNAJC21
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS2480590542 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480591221 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480591628 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480592535 |
MSX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranium bifidum occultum, Inborn genetic diseases |
| RS2480597096 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480597386 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480597949 |
DNAJC21
|
Health Risk |
Pathogenic |
— |
| RS2480598071 |
ITK
|
Health Risk |
Pathogenic |
— |
| RS2480599117 |
DNAJC21
|
Health Risk |
Pathogenic |
— |
| RS2480603008 |
MSX2
|
Health Risk |
Pathogenic |
Craniosynostosis 2, Craniosynostosis 2 |
| RS2480610077 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480610173 |
PDE6A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 43, Retinitis pigmentosa 43 |
| RS2480610422 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480614303 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480614730 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480618246 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS2480618469 |
F13A1
|
Health Risk |
Likely pathogenic |
— |
| RS2480618478 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS2480631479 |
DNAJC21
|
Health Risk |
Likely pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS2480641681 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480641733 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480651992 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS2480663838 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480664088 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480664753 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS2480664913 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480676071 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480678697 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480679636 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480679840 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480685391 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480693529 |
H1-4
|
Health Risk |
Pathogenic |
Rahman syndrome, Rahman syndrome |
| RS2480693538 |
H1-4
|
Health Risk |
Pathogenic |
Rahman syndrome, Rahman syndrome |
| RS2480693817 |
H1-4
|
Health Risk |
Pathogenic |
— |
| RS2480693825 |
H1-4
|
Health Risk |
Pathogenic |
H1-4-related disorder, H1-4-related disorder |
| RS2480712420 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS2480719857 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS2480720249 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480720376 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480729692 |
NSD1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2480730115 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480730192 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480730450 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480749096 |
NSD1
|
Health Risk |
Likely pathogenic |
NSD1-related disorder, NSD1-related disorder |
| RS2480749099 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480749805 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480749822 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480758383 |
BLTP1
|
Health Risk |
Likely pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS2480770046 |
SLC26A2
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia |
| RS2480770174 |
SLC26A2
|
Health Risk |
Likely pathogenic |
— |